Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.0808508 on December 3, 2008

Published online before print December 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
jlb.0808508v1
85/3/491    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gove, M. E.
Right arrow Articles by Fantuzzi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gove, M. E.
Right arrow Articles by Fantuzzi, G.
(Journal of Leukocyte Biology. 2009;85:491-496.)
© 2009 by Society for Leukocyte Biology

Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice

Melissa E. Gove*, Davina H. Rhodes*, Maria Pini*, Jantine W. van Baal*, Joseph A. Sennello*, Raja Fayad*, Robert J. Cabay{dagger}, Martin G. Myers, Jr{ddagger} and Giamila Fantuzzi*,1

* Departments of Kinesiology and Nutrition and
{dagger} Pathology, University of Illinois at Chicago, Chicago, Illinois, USA; and
{ddagger} Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA

1 Corresondence: Kinesiology and Nutrition Department, University of Illinois at Chicago, Chicago, IL 60612, USA. E-mail: giamila{at}uic.edu

Leptin-deficient ob/ob mice are resistant to dextran sulfate sodium (DSS)-induced colitis and Concanavalin A (Con A)-induced hepatitis. However, the signal transduction pathways involved have not been identified. The present study investigated the effect of leptin-induced STAT3 signaling in the DSS and Con A models. Mice carrying a leptin receptor (LEPR) gene mutant for Y1138 (s/s mice), with abrogated leptin-induced STAT3 signaling, were compared with wild-type (WT) and LEPR-deficient db/db mice. Administration of DSS to s/s mice resulted in a clinical score and colon shortening of intermediate severity compared with disease induced in WT and db/db mice—the latter group having the lowest disease severity. A comparable degree of inflammatory infiltrate and epithelial damage was observed in the colon of WT and s/s mice, and these parameters were reduced in db/db mice. Levels of IFN-{gamma}, IL-6, IL-10, and TNF-{alpha} were comparable in the colon of s/s and db/db mice, and a similar trend was observed for CXCL2. s/s and WT mice developed severe liver disease in response to Con A, whereas db/db mice were protected. However, Con A-induced serum IL-6 and TNF-{alpha} levels in s/s mice mimicked levels observed in db/db rather than WT mice. In conclusion, lack of leptin-induced STAT3 signaling is associated with reduced cytokine production following DSS and Con A administration, but it appears to sensitize mice to the effects of proinflammatory mediators.

Key Words: cytokines • colon • liver